Drug Discovery Today: TARGETS

Show Articles
Journal Properties
  • Incorporated into
    Drug Discovery Today
  • Language
    English
  • Number of Articles
    70
  • ISSN
    1741-8372
  • Main Publisher
    Elsevier
  • Publisher
    Elsevier BV
  • Indian UGC
  • DOAJ (latest)
Description
Drug Discovery Today: TARGETS focuses on target identification and validation in drug discovery, providing insights into novel therapeutic targets and strategies. It examines the latest technologies and approaches used to identify and validate drug targets, offering a comprehensive overview of advancements in the field. It serves as a valuable resource for researchers seeking to develop effective new treatments. Key areas covered include genomics, proteomics, bioinformatics, and high-throughput screening. Indexed in major pharmaceutical and scientific databases, this journal appeals to researchers, drug developers, and scientists in the pharmaceutical industry. Specific topics include target-based drug design, personalized medicine, and the ethical implications of drug discovery. Articles in Drug Discovery Today: TARGETS offer perspectives on the latest scientific breakthroughs, accelerating the development of targeted therapies. Discover new possibilities in pharmaceutical innovation. Submit your research and help shape the future of drug discovery.